MedTrace Logo

The Impact of Pulmonary Rehabilitation in Interstitial Lung Disease

NCT01055730 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 54

Last updated 2013-11-21

No results posted yet for this study

Summary

The purpose of this study is to determine if pulmonary rehabilitation has any effect on breathlessness, quality of life, physical function and depression in persons with interstitial lung disease.

Conditions

Interventions

OTHER

Pulmonary rehabilitation

Structured education and supervised exercise program, lasting between 6 and 9 weeks.

Sponsors & Collaborators

Principal Investigators

  • Harold R Collard, MD · University of California, San Francisco

  • Christopher J Ryerson, MD · University of California, San Francisco

  • Chris Garvey, FNP · Seton Pulmonary & Cardiac Rehabilitation

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2013-01-31
Completion
2013-01-31

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01055730 on ClinicalTrials.gov